U.S. wage growth is cooling, but some jobs are still seeing relatively big annual raises
https://www.cnbc.com/2024/04/15/us-wage-growth-is-cooling-but-its-still-hot-in-these-jobs.html
Apr 15, 2024 - The growth in workers' annual earnings has retreated from an initial surge during the Covid-19 pandemic. But some jobs are still paying healthy raises.
0
Wall Street Analysts See a 25.23% Upside in Chart Industries (GTLS): Can the Stock Really Move This High?
https://www.zacks.com/stock/news/2255332/wall-street-analysts-see-a-25-23-upside-in-chart-industries-gtls-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2255332
Apr 15, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Chart Industries (GTLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
0
Wall Street Analysts See Crescent Point (CPG) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2255218/wall-street-analysts-see-crescent-point-cpg-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2255218
Apr 15, 2024 - According to the average brokerage recommendation (ABR), one should invest in Crescent Point (CPG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare
Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
0
Half of Wall Street Covering Analysts Are Calling This Beaten-Down Stock a Buy Right Now, and 1 Sees a 60% Upside
https://www.fool.com/investing/2024/04/14/half-of-wall-street-covering-analysts-are-calling/?source=iedfolrf0000001
Apr 14, 2024 - There might be a rebound happening even now.
0
Fundstrat's Tom Lee sees S&P 500 potentially ending the year at 5,700 points
https://seekingalpha.com/news/4089417-fundstrats-tom-lee-sees-sp-500-potentially-ending-the-year-at-5700-points?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Apr 13, 2024 - Fundstrat's Tom Lee has made a bullish call about the market with a 5,700 points prediction for the benchmark S&P 500. Read more here.
0
BT Group: Still Seeing Little Love From The Market
https://seekingalpha.com/article/4683616-bt-group-still-seeing-little-love-from-the-market-btgof-stock?source=feed_all_articles
Apr 13, 2024 - BT's shares continue to trade at a steep discount to European peers and my fair value estimate, offering a strong value case for patient investors. Explore more here.
0
Brent crude tops $90 on Mideast fears, but IEA sees slower global oil demand growth
https://seekingalpha.com/news/4089399-brent-crude-tops-90-on-mideast-fears-but-iea-sees-slower-global-oil-demand-growth?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Apr 12, 2024 - Crude oil futures rise amid concerns of possible attack by Iran on Israel, outweighing the International Energy Agency's bearish monthly report forecasting slower global oil demand growth.
0
Core & Main (CNM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
https://www.zacks.com/stock/news/2254837/core-main-cnm-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2254837
Apr 12, 2024 - Core & Main (CNM) concluded the recent trading session at $56.34, signifying a -1.47% move from its prior day's close.
0
Wall Street Analysts See Byrna Technologies (BYRN) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2254423/wall-street-analysts-see-byrna-technologies-byrn-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2254423
Apr 12, 2024 - According to the average brokerage recommendation (ABR), one should invest in Byrna Technologies (BYRN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0